![David Gaugh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Gaugh
Vorstandsvorsitzender bei Association for Accessible Medicines
Aktive Positionen von David Gaugh
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Association for Accessible Medicines
![]() Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Vorstandsvorsitzender | 07.12.2022 | - |
General Counsel | - | 07.12.2022 | |
Corporate Officer/Principal | 10.01.2012 | - |
Karriereverlauf von David Gaugh
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Chief Executive Officer | 1 |
General Counsel | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Association for Accessible Medicines
![]() Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
- Börse
- Insiders
- David Gaugh
- Erfahrung